Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. (Record no. 27192087)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02113 a2200577 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517154127.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201805s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1569-8041 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1093/annonc/mdx266 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ali, H R |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180507 |
245 00 - TITLE STATEMENT | |
Title | Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Annals of oncology : official journal of the European Society for Medical Oncology |
Date of publication, distribution, etc. | Aug 2017 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1832-1835 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Bevacizumab |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Breast Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Computational Biology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cyclophosphamide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Epirubicin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Fluorouracil |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocyte Count |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocytes |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lymphocytes, Tumor-Infiltrating |
General subdivision | pathology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoadjuvant Therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Polymerase Chain Reaction |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Remission Induction |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dariush, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Provenzano, E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dunn, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hiller, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vallier, A-L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Abraham, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Piper, T |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bartlett, J M S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cameron, D A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hayward, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brenton, J D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pharoah, P D P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Irwin, M J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Walton, N A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Earl, H M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Caldas, C |
773 0# - HOST ITEM ENTRY | |
Title | Annals of oncology : official journal of the European Society for Medical Oncology |
Related parts | vol. 28 |
-- | no. 8 |
-- | p. 1832-1835 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1093/annonc/mdx266">https://doi.org/10.1093/annonc/mdx266</a> |
Public note | Available from publisher's website |
No items available.